Search

Search Constraints

You searched for: Author/Creator Innocenti, Idanna

Search Results

1. Adverse drug reactions after intravenous rituximab infusion are more common in hematologic malignancies than in autoimmune disorders and can be predicted by the combination of few clinical and laboratory parameters: results from a retrospective, multicenter study of 374 patients. Issue 11 (2nd November 2017)

2. Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience. Issue 10 (2nd October 2016)

3. Autologous peripheral blood stem cell transplantation and the role of lenalidomide in patients affected by poems syndrome. Issue 2 (15th September 2017)

4. Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments. Issue 10 (October 2015)

5. Blinatumomab as a successful and safe therapy in Down syndrome patients with relapsed/refractory b‐precursor acute lymphoblastic leukaemia: Case reports and literature review. Issue 7 (12th April 2021)

6. CD200 included in a 4‐marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia. Issue 3 (30th March 2018)

7. Characterization and prognostic relevance of circulating microvesicles in chronic lymphocytic leukemia. Issue 6 (3rd June 2017)

8. Circulating Regulatory T-Cells in Monoclonal Gammopathies of Uncertain Significance and Multiple Myeloma: In Search of a Role. (14th July 2016)

9. Clinical, pathological, and biological characterization of Richter syndrome developing after ibrutinib treatment for relapsed chronic lymphocytic leukemia. Issue 3 (27th February 2018)

10. Comparison between the CLL‐IPI and the Barcelona‐Brno prognostic model: Analysis of 1299 newly diagnosed cases. Issue 2 (23rd November 2017)